Blog Articles

Chromosomal aneuploidies are the most common cause of first-trimester miscarriage, accounting for approximately 50% of spontaneous abortions.

Newborn screening is a worldwide recognised public health measure aimed at the early screening, diagnosis and management of selected metabolic diseases.

Discover how pre-implantation genetic screening can reduce the risk of miscarriage and genetic conditions during IVF.

Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).

Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.

Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.

Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.

The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.

A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population.